Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)

Clinical trial NCT03792516 · COMPLETED

Trial details

NCT number: NCT03792516
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vulvar Dysplasia HPV-Related Vulvar Intraepithelial Neoplasia Preinvasive Vulvar Disease Vulva Intraepithelial Neoplasia Vulvar Diseases

Start date: 2019-04-17
Primary completion: 2022-08-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.